Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Colorcon
Federal Trade Commission
Argus Health
Cantor Fitzgerald
QuintilesIMS
Julphar
McKinsey
Baxter

Generated: April 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: brivaracetam

« Back to Dashboard

brivaracetam

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Ucb Inc BRIVIACT brivaracetam SOLUTION;INTRAVENOUS 205837 NDA UCB, Inc. N 50474-970-75
Ucb Inc BRIVIACT brivaracetam SOLUTION;ORAL 205838 NDA UCB, Inc. N 50474-870-15
Ucb Inc BRIVIACT brivaracetam TABLET;ORAL 205836 NDA UCB, Inc. N 50474-370-66
Ucb Inc BRIVIACT brivaracetam TABLET;ORAL 205836 NDA UCB, Inc. N 50474-470-12
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cipla
Argus Health
Dow
Deloitte
Federal Trade Commission
Fish and Richardson
QuintilesIMS
Baxter